Trial | NCT00561535  Report issue

Title

Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients
Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    60
Probiotics may improve symptoms in IBS patients. The aim of this study is to test the efficacy of Lactobacillus FARCIMINIS in diarrhea predominant IBS patients according to Rome III criteria.
The aim of this study is to test the efficacy of Lactobacillus FARCIMINIS in diarrhea predominant IBS patients according to Rome III criteria.
Study Started
Oct 31
2007
Primary Completion
May 31
2010
Study Completion
Jun 30
2010
Last Update
Jan 27
2011
Estimate

Dietary Supplement Lactobacillus FARCIMINIS

10.10 UFC of lactobacillus FARCIMINIS

  • Other names: 10.10 UFC of lactobacillus FARCIMINIS

Dietary Supplement placebo (starch)

Once daily

  • Other names: Once daily

A Experimental

Lactobacillus FARCIMINIS

B Placebo Comparator

Placebo

Criteria 

Inclusion Criteria:

Diarrhea predominant IBS
Less than 5-year duration
Pain intensity between 2 and 7 on VAS

Exclusion Criteria:

Celiac disease
Antibiotic treatment within the 1-month period preceding inclusion
Digestive organic disease
Any severe non digestive organic disease
No Results Posted